The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GM Result, Issue of Equity and Total Voting Rights

21 May 2021 11:14

RNS Number : 4548Z
Location Sciences Group PLC
21 May 2021
 

 

 

21 May 2021

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Result of General Meeting, Issue of Equity and Total Voting Rights

 

 

 

Result of General Meeting

 

The Company is pleased to announce that at its General Meeting held earlier today in connection with the proposed fundraise and Board changes announced on 4 May 2021, all Resolutions were put to the meeting and were duly passed. The voting results from the General Meeting are included at the end of this announcement.

 

Issue of new Ordinary Shares in consideration for cancellation of warrants

 

The Company announces that it has also agreed with the existing warrant holder in the Company to surrender all warrants over Ordinary Shares issued pursuant to the warrant instrument dated 12 December 2016, in consideration for the issue and allotment of 5,000,000 new Ordinary Shares at 0.2 pence per new Ordinary Share in the Company (the "Warrant Cancellation Shares"). The Warrant Cancellation Shares will be issued utilising the Company's existing share authorities put in place at the Company's annual general meeting held on 9 April 2020 and by way of a subscription with the Company.

 

Admission of New Ordinary Shares

 

Application has been made to the London Stock Exchange for 2,017,750,000 new Ordinary Shares, which comprises the Placing Shares, the Subscription Shares, the Fees Shares (excluding 42,500,000 Fees Shares in respect of the second year's fees of the Proposed Directors), the Broker Option Shares and the Warrant Cancellation Shares, to be admitted to trading on AIM. It is anticipated that Admission will occur and that dealings will commence in the New Ordinary Shares at 8.00 a.m. on 25 May 2021.

 

Total Voting Rights

 

Following Admission, the Company will have 2,605,087,398 Ordinary Shares in issue. The Company holds no shares in treasury. Therefore, the Company hereby confirms that the total number of voting rights in the Company will, following Admission, be 2,605,087,398.

 

Shareholders may use this figure of 2,605,087,398 as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

A separate announcement will be made relating to the planned Board changes which will become effective immediately following Admission.

 

A copy of this announcement is available on the Company's website https://www.locationsciencesgroup.ai/investor-relations/rns-news-alerts/.  

 

Terms defined in the circular to shareholders published by the Company on 4 May 2021 shall have the same meanings when used in this announcement.

 

 

For further information please contact:

 

Location Sciences Group PLC via Milk & Honey PR

Mark Slade, Chief Executive Officer

David Rae, CFO and Commercial Director

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

David Worlidge

 

Turner Pope Investments (TPI) Ltd (Placing Agent) Tel: +44 (0)20 3657 0050

James Pope

Andy Thacker

 

Peterhouse Capital (Broker) Tel: +44 (0) 20 7220 9791

Charles Goodfellow

Eran Zucker

 

Milk & Honey PR Tel: +44 (0)20 3637 7310

Kirsty Leighton

Jessica Ballinger

 

 

 

 

No.

Resolution

 

For*

Against

1

To approve the waiver granted by the Panel on Takeovers and Mergers described in the Circular.

91.2%

8.8%

2

To grant the Directors authority to allot equity securities in the Company in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

3

To grant the Directors authority to allot equity securities in the Company for cash as if section 561 of the Act did not apply in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

4

To elect Simon Wilkinson as a Director with effect from Admission.

95.6%

4.4%

5

To elect Dr Nigel Burton as a Director with effect from Admission.

95.6%

4.4%

 

* Includes proxies received to be voted at the discretion of the Chairman.

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMMZGZKGMFGMZM
Date   Source Headline
27th Jul 20164:00 pmRNSHolding(s) in Company
27th Jul 20164:00 pmRNSHolding(s) in Company
25th Jul 20163:30 pmRNSResult of AGM and GM
25th Jul 20167:00 amRNSAGM Statement
15th Jul 20164:52 pmRNSDirectorate Change
27th Jun 20164:00 pmRNSNotice of AGM Posting of Circular/Annual Report
24th Jun 201612:15 pmRNSResult of Placing
24th Jun 20167:01 amRNSProposed Placing
24th Jun 20167:00 amRNSFinal Results
4th May 20169:15 amRNSLondon Buses Advertising Campaigns
30th Mar 20167:00 amRNSIssue of Deferred Consideration Shares
17th Mar 201610:29 amRNSHolding(s) in Company
9th Mar 20167:00 amRNSNew Partnership with Google
29th Jan 20167:00 amRNSPre-Close Trading Statement
17th Dec 20157:00 amRNSNew contract and Trading update
11th Dec 20157:00 amRNSNew Contract
21st Sep 20157:00 amRNSHalf Yearly Report
16th Sep 20157:00 amRNSNew contract
7th Sep 20157:00 amRNSNew Contract
31st Jul 20157:00 amRNSNew Contract Win
22nd Jul 20157:00 amRNSNew Contract Win
15th Jul 20157:00 amRNSDirectorate Change
1st Jul 20157:00 amRNSDeployment of beacons on London buses
30th Jun 20151:40 pmRNSResult of AGM
10th Jun 20157:00 amRNSDigital Enablement Platform
4th Jun 201511:00 amRNSNotice of AGM
20th May 20157:01 amRNSNew Contract Win
20th May 20157:00 amRNSFinal Results
19th May 20157:00 amRNSNew Contract Win and Government Grant
18th May 20157:00 amRNSAirports contract win and notice of results
5th Mar 20157:00 amRNSDirector Resignation
3rd Feb 20157:00 amRNSPre-Close Trading Statement
28th Jan 20159:30 amRNSNotice of pre-close Trading Update
22nd Jan 20157:00 amRNSTR1 Notification of Major Interest in Shares
20th Jan 20157:00 amRNSBoard Appointments
9th Dec 20147:00 amRNSUpdate in relation to Placing
5th Dec 20147:00 amRNSAcquisition of Aconite Technology Limited
28th Nov 201412:15 pmRNSResult of Meeting
24th Nov 20147:00 amRNSNorwich buses equipped with PROXAMA technology
4th Nov 201412:04 pmRNSPosting of the Circular to Shareholders
4th Nov 20147:00 amRNSProposed placing and Possible Acquisition
24th Sep 20147:00 amRNSHalf Yearly Report
15th Sep 20143:03 pmRNSHolding(s) in Company
15th Sep 201412:55 pmRNSStatement Re WEVE
15th Sep 20147:00 amRNSNFC on iPhone 6 and Apple Watch
10th Sep 201411:00 amRNSNotice of Results
21st Aug 20147:00 amRNSMobile Digital Proximity Technology at Kia Oval
13th Aug 20147:00 amRNSMobile Digital Proximity Technology For Liverpool
30th Jul 20147:00 amRNSTrading Update
19th Jun 20147:00 amRNSPROXAMA SECURES "CONNECTED" HIGH STREET PROJECT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.